SCHEMBL4068264

SCHEMBL4068264

CC[C@H](CO)Nc1nc(Nc2cccc(S(=O)(=O)NCc3cccc(F)c3)c2)ncc1Br

nearest known ligand 0.52

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ NTRK1 P04629 6/20 0.52
▸ PTK2 Q05397 2/20 0.44
▸ CDK1 P06493 6/20 0.44
▸ KDR P35968 5/20 0.44
▸ CDK2 P24941 5/20 0.44
▸ CA2 P00918 2/20 0.44
▸ CDK4 P11802 2/20 0.44
▸ CDK7 P50613 2/20 0.44
▸ CDK9 P50750 2/20 0.44
▸ CCNT1 O60563 1/20 0.44
▸ CCND1 P24385 1/20 0.44
▸ CCNH P51946 1/20 0.44
▸ CCNB1 P14635 2/20 0.43
▸ CCNE1 P24864 2/20 0.43
▸ TBK1 Q9UHD2 3/20 0.43
▸ JAK2 O60674 1/20 0.42
▸ JAK3 P52333 1/20 0.42
▸ BRD4 O60885 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4064128 0.93 NTRK1 (0.51) NTRK1PTK2CDK1KDRCDK2
SCHEMBL13427724 0.93 NTRK1 (0.51) NTRK1PTK2CDK1KDRCDK2
SCHEMBL4060305 0.93 CDK1 (0.45) NTRK1PTK2CDK1KDRCDK2
SCHEMBL4063086 0.90 KDR (0.56) NTRK1PTK2CDK1KDRCDK2
SCHEMBL4069893 0.90 TRPV1 (0.43) NTRK1PTK2CDK1KDRCDK2
SCHEMBL4066529 0.90 CDK2 (0.45) PTK2CDK1KDRCDK2CA2
SCHEMBL4061041 0.89 CDK1 (0.45) NTRK1PTK2CDK1KDRCDK2
SCHEMBL4060679 0.89 CDK1 (0.45) NTRK1PTK2CDK1KDRCDK2
SCHEMBL4059716 0.88 NTRK1 (0.43) NTRK1PTK2CDK1KDRCDK2
SCHEMBL4059539 0.88 TBK1 (0.43) NTRK1PTK2CDK1KDRCDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392662-B1 CDK INHIBITING PYRIMIDINES, PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BAYER SCHERING PHARMA AG (DE) 2009-01-07 — — EP claimed
US-7598260-B2 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-10-06 — — US disclosed
US-7598260-B2 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-10-06 — — US disclosed
EP-1392662-B1 CDK INHIBITING PYRIMIDINES, PRODUCTION THEREOF AND THEIR USE AS MEDICAMENTS BAYER SCHERING PHARMA AG (DE) 2009-01-07 — — EP disclosed
US-7291624-B2 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents BAYER SCHERING PHARMA AG (DE) 2007-11-06 — — US disclosed
US-7291624-B2 CDK-inhibitory pyrimidines, their production and use as pharmaceutical agents BAYER SCHERING PHARMA AG (DE) 2007-11-06 — — US disclosed
US-7235561-B2 Compound and a composition including such a compound SCHERING AG (DE) 2007-06-26 — — US disclosed
US-7235561-B2 Compound and a composition including such a compound SCHERING AG (DE) 2007-06-26 — — US disclosed
Send feedback